J.G. Petrucci Company, Inc. Celebrates Grand Opening of Aurobindo Pharma USA’s New 170,000-Square-Foot Facility in East Windsor Township

J.G. Petrucci Company, Inc. (Petrucci), one of New Jersey and Pennsylvania’s most respected Development and Design/Build organizations, proudly joined Aurobindo Pharma USA, Inc. (Aurobindo) in celebrating the grand opening of its new 170,000-square-foot pharmaceutical facility on Windsor Center Drive in East Windsor Township. The facility was constructed over a ten-month period and enhances Aurobindo’s capacity to deliver high-quality, affordable pharmaceutical products to patients worldwide.

The new building expands Aurobindo’s North American headquarters campus, which also includes a 606,620-square-foot distribution center and the 43,000-square-foot Patscenter facility along Princeton Hightstown Road. The new facility predominantly houses over-the-counter and injectable products, complementing the company’s existing operations focused on solid oral dosage forms.

Swami S. Iyer, Chief Executive Officer of Aurobindo Pharma USA, Inc., added, “Aurobindo’s expansion in East Windsor reflects our commitment to progress: creating jobs, fostering innovation, and strengthening ties with the local community. We’re grateful to partner with Petrucci, whose deep expertise and collaboration have helped bring this vision to life in record time.”

The new building features energy-efficient systems and thoughtfully designed outdoor amenities, including walkways, patios, and landscaped seating areas to create a cohesive campus experience. The project reflects Aurobindo’s continued investment in sustainable, forward-looking facilities that support both innovation and workforce well-being.

“Delivering this facility in under a year speaks to the strength of our collaboration with Aurobindo,” said Joe Petrucci, Project Executive at J.G. Petrucci. “The Aurobindo team, specifically Swami, Srikanth, Johan, and Nitin, have been tremendous partners, and we look forward to working with them on future projects.”

About Aurobindo Pharma USA, Inc.

Aurobindo Pharma USA, Inc. is a generic pharmaceutical manufacturer and distributor and is a wholly owned subsidiary of Aurobindo Pharma Limited, a leading generic pharmaceutical company based in India. Headquartered in Hyderabad, India, founded in 1986 and becoming a public company in India in 1992. Aurobindo is committed to delivering a broad portfolio of quality, affordable generic pharmaceuticals. Aurobindo Pharma USA, Inc. adds value through superior customer service in the distribution of a broad line of generic pharmaceuticals, leveraging vertical integration and efficient controlled processes.